{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:58:23Z","timestamp":1773021503272,"version":"3.50.1"},"reference-count":18,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.3960\/jslrt.17025","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T22:10:15Z","timestamp":1507759815000},"page":"47-53","source":"Crossref","is-referenced-by-count":4,"title":["Characteristics and Prognosis of Patients with Immunoglobulin M Monoclonal Gammopathy"],"prefix":"10.3960","volume":"57","author":[{"given":"Hiroaki","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Hematology, Asahi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Asahi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asahi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Asahi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Asahi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Asahi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Hobbs JR, Carter PM, Cooke KB, Foster M, Oon CJ : IgM paraproteins. J Clin Pathol Suppl 6 : 54-64, 1975","DOI":"10.1136\/jcp.s1-6.1.54"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lin P, Hao S, Handy BC, Bueso-Ramos CE, Medeiros LJ : Lymphoid neoplasms associated with IgM paraprotein : a study of 382 patients. Am J Clin Pathol 123 : 200-205, 2005","DOI":"10.1309\/2A0F-L1HM-5PN2-510P"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Oza A, Rajkumar SV : Waldenstrom macroglobulinemia : prognosis and management. Blood Cancer J 5 : e394, 2015","DOI":"10.1038\/bcj.2015.28"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Vijay A, Gertz MA : Waldenstrom macroglobulinemia. Blood 109: 5096-5103, 2007","DOI":"10.1182\/blood-2006-11-055012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Kanda Y : Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical s tatistics. Bone Marrow Transplant 48:452-458, 2013","DOI":"10.1038\/bmt.2012.244"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 International Myeloma Working Group : Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121 : 749-757, 2003","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"7","unstructured":"7 Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, <i>et al<\/i>. : Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom\u2019s macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system. J Clin Oncol 23:4662-4668, 2005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Iwanaga M, Tagawa M, Tsukasaki K, Kamihira S, Tomonaga M: Prevalence of monoclonal gammopathy of undetermined significance : study of 52,802 persons in Nagasaki City, Japan. Mayo Clin Proc 82 : 1474-1479, 2007","DOI":"10.1016\/S0025-6196(11)61090-2"},{"key":"9","unstructured":"9 Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, <i>et al<\/i>. : Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 102 : 3759-3764, 2003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kyle RA, Garton JP : The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62 : 719-731, 1987","DOI":"10.1016\/S0025-6196(12)65225-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Pasqualetti P, Festuccia V, Collacciani A, Casale R : The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases. Acta Haematol 97 : 174-179, 1997","DOI":"10.1159\/000203676"},{"key":"12","unstructured":"12 Owen RG, Parapia LA, Higginson J, Misbah SA, Child JA, <i>et al<\/i>. : Clinicopathological correlates of IgM paraproteinemias. Clin Lymphoma 1 : 39-43, 2000"},{"key":"13","unstructured":"13 Attygalle AD, Kyriakou C, Dupuis J, Grogg KL, Diss TC, <i>et al<\/i>. : Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies : clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 31 : 1077-1088, 2007"},{"key":"14","unstructured":"14 Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, <i>et al<\/i>. : Primary chronic cold agglutinin disease : a population based clinical study of 86 patients. Haematologica 91 : 460-466, 2006"},{"key":"15","unstructured":"15 Tanaka H, Hashimoto S, Sugita Y, Sakai S, Takeda Y, <i>et al<\/i>. : Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy. Int J Hematol 96 : 501-505, 2012"},{"key":"16","unstructured":"16 Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, <i>et al<\/i>. : Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders : IWWM-7 consensus. Blood 124 : 1404-1411, 2014"},{"key":"17","unstructured":"17 Kyle RA, Benson JT, Larson DR, Therneau TM, Dispenzieri A, <i>et al<\/i>. : Progression in smoldering Waldenstrom macroglobulinemia : long-term results. Blood 119 : 4462-4466, 2012"},{"key":"18","unstructured":"18 Dhodapkar MV, Hoering A, Gertz MA, Rivkin S, Szymonifka J, <i>et al<\/i>. : Long-term survival in Waldenstrom macroglobulinemia : 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003. Blood 113 : 793-796, 2009"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/57\/2\/57_17025\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T14:02:58Z","timestamp":1570197778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/57\/2\/57_17025\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.17025","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}